Last $48.91 USD
Change Today -2.83 / -5.47%
Volume 1.7M
RMD On Other Exchanges
New York
As of 10:49 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

resmed inc (RMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/22/13 - $57.34
52 Week Low
02/3/14 - $41.52
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RESMED INC (RMD)

resmed inc (RMD) Related Businessweek News

No Related Businessweek News Found

resmed inc (RMD) Details

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices for the treatment of sleep-disordered breathing that includes obstructive sleep apnea and other respiratory disorders, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators, as well as humidifiers, which connect with the continuous and variable positive airway pressure, and autoset flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

3,900 Employees
Last Reported Date: 08/13/13
Founded in 1989

resmed inc (RMD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $511.2K
President and Chief Operating Officer
Total Annual Compensation: $588.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $505.3K
President of SDB Strategic Business Unit
Total Annual Compensation: $385.0K
President of Americas
Total Annual Compensation: $379.8K
Compensation as of Fiscal Year 2013.

resmed inc (RMD) Key Developments

ResMed Inc. Declares Quarterly Dividend, Payable on September 18, 2014

ResMed Inc. board of directors has declared a quarterly dividend of $0.28 per share, which represents a 12% increase from the previous quarterly dividend of $0.25. The dividend will have a record date of August 21, 2014, and be payable on Sept. 18, 2014. The dividend will be paid in U.S. currency to holders of ResMed's common stock trading on the New York Stock Exchange. Holders of Chess Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be Aug. 19, 2014 for common stock holders and for CDI holders. ResMed has received a waiver from the ASX's settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from Aug. 19, 2014 through Aug. 21, 2014, inclusive.

ResMed Inc. to Report Q4, 2014 Results on Jul 31, 2014

ResMed Inc. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Jul 31, 2014

ResMed Inc., Q4 2014 Earnings Call, Jul 31, 2014

ResMed Inc., Q4 2014 Earnings Call, Jul 31, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMD:US $48.92 USD -2.82

RMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $26.05 USD -0.02
IDEXX Laboratories Inc $124.76 USD +0.28
Mettler-Toledo International Inc $254.92 USD -2.22
Teleflex Inc $106.42 USD -1.32
Cooper Cos Inc/The $160.55 USD -0.33
View Industry Companies

Industry Analysis


Industry Average

Valuation RMD Industry Range
Price/Earnings 22.7x
Price/Sales 4.7x
Price/Book 4.3x
Price/Cash Flow 21.3x
TEV/Sales 3.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at